TGen and ABL pursue global rollout of advanced TB test Posted Monday March 18, 2019 Licensing agreement puts DeepChek®-TB one step closer to clinical application
Flinn Foundation awards ‘Prevent HAARM’ grant to C-Path and TGen Posted Tuesday January 8, 2019 $400,000 grant aims to develop a genomic surveillance system to respond to antimicrobial resistant pathogens